Open access
Aug 2026
Improved glycemic control with the MiniMed 780G system in latent autoimmune diabetes and type 1 diabetes: a real-world observational study.
MiniMed™ 780G markedly improves glycemic control in people with LADA, supporting AHCLS as an effective therapeutic strategy in this population of insulin-treated patients with latent autoimmune diabetes in adults.
F. De Vita, S. Zampetti, Alessandro Latino et al.
· Diabetes Research and Clinic... · 0 citations